Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (8033)	12/12/1998 7:56:00 PM
From: Tharos	Respond to of 17367

Bob, had a chance to fire up my search engine again, more than 400 new listings (from when I last searched). Am halfway through and found these links interesting, espec. the Hawaii one (Xomazime). New meds for CF being studied www3.nbnet.nb.ca August 26, 1996 Cured? Xoma back from death's door amcity.com Structural studies of human bactericidal/permeability-increasing protein biochem.missouri.edu NOT SPECIFICALLY XOMA RELATED, just lots of biotech info links univie.ac.at Studies and Publications by Researchers in Hawaii LIVINGSTON WONG,MD Studies and Publications: "Autologous bone marrow transplant in acute non-lymphocytic leukemia in remission, using 4-hydroperoxycyclo-phosphamide treated bone marrow" Allogenic bone marrow transplant with high dose combination chemotherappy with or without radiation in patients with refractory Hodgkin's disease & non-Hodgkin's lymphoma Bone marrow transplantation using HLA-matched unrelated donor. Xomazyme-H65 (Xomazyme CO-5 plus) use in treatment of CVH or rejection. End of listings for : WONG, LIVINGSTON , MD pixi.com